Navigation Links
US science education organization updates analysis
Date:2/6/2009

Revamped edition examines the media, polls, new legal challenges, intelligent design in the courts, and more.

The evolution wars are over, right? Scopes was finally vindicated, creationism was booted out of the classroom, and a new president in his inaugural speech issued a clarion call to "restore science to its rightful place".

Wrong. Evolution education is being battered every day in school districts across the U.S. by creationists, whether they're pushing young-earth creationism, intelligent design, or antievolutionism in the guise of "academic freedom".

What's going on here? Why is the United States the only country where teaching evolution is so controversial? Why are scientists so sure that evolution is good science? Are people of faith truly unable to accept the central principle of modern biology? Is it really "fair" for creationism to be taught alongside evolution? What have the courts said? And will attacks on evolution ultimately undermine not only American education but American competitiveness?

These and many other questions are answered in the 2nd edition of Evolution vs. Creationism, Dr. Eugenie Scott's lucid and comprehensive look at this ongoing debate. Dr. Scott, one of the leading promoters and defenders of teaching evolution in the schools, dissects these ever-changing efforts to undermine science education. Praised for its balance and comprehensiveness, the book places the issues in today's headlines into historical, cultural, religious, educational, and scientific perspective as no other book does.

Updated, revamped, and expanded, the 2nd edition adds another 70 pages of brand new and revised material, including:

  • A new foreword by U.S. District Judge John E. Jones III, who ruled in the landmark Kitzmiller v. Dover case.
  • A new chapter on testing intelligent design and evidence against evolution in the courts.
  • A
    '/>"/>

Contact: Robert Luhn
luhn@ncseweb.org
510-601-7203
American Institute of Physics
Source:Eurekalert

Page: 1 2

Related biology news :

1. National Science Foundation forum to address ecological connectivity and climate in a changing world
2. BioScience tip sheet, February 2009
3. American Association for Cancer Research hosts Science of Cancer Health Disparities conference
4. Experts discuss challenges in integrative approaches to science
5. New report on science learning at museums, zoos, other informal settings
6. Springer author and advisory board member wins LOreal UNESCO Women in Science Award
7. Springer expands its portfolio in plant sciences with Phytoparasitica
8. Louisiana Tech physicists highlight top 10 science stories of 2008
9. First Science from the Compact Light Source: A miniature synchrotron for your home lab
10. American Association for Cancer Research hosts Science of Health Care Disparities Meeting
11. BioScience tip sheet, January 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... , CINCINNATINew research presents strong evidenc...sure to both outdoor traffic-related pollution and...ungs than one or the other exposure alone. , E...f Cincinnati (UC) College of Medicine have shown t...c-related particles and indoor endotoxin during ea...
(Date:11/23/2009)... , TORONTO, November 23, 2009 - The time of day...ording to a new paper produced by a research team ...oronto Scarborough,s vice-principal for research a...s biology at the St. George campus. , Capitali...f the poplar tree, the research team examined how ...
(Date:11/23/2009)... , Farmington, CT Current research suggests that... disease. The related report by Nichols et al, "U...nt a New Class of TLR2 Ligands Capable of Enhancin...e of The American Journal of Pathology . , Mult...stem attacks the brain and spinal cord, affects ne...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 1Diabetes drug kills cancer stem cells in combination treatment in mice 9909 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 3Alert status area in brain discoved by Hebrew University scientists 9907 1Alert status area in brain discoved by Hebrew University scientists 9907 2Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 1Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 2
...oth pass on "traditions" to other members of their...ng behaviour. The findings add to evidence that cu...e study involved killerwhales at Marineland in Nia...evised a brand new way to catch birds, and passed ...orca lures gulls into his tank by spitting regurgi...
...ribed to patients with the common cold because the...nd the benefits do not outweigh the risks, accordi... , "Antibiotics appear to have no benefit in the t...ns," conclude Dr. Bruce Arroll and Dr. Timothy Ken...The implications for practice are that prescriptio...
...ands of biologists around the globe run DNA sequen...nline algorithm called BLAST ?typically submitting...de, to be matched against the billions of letters ...an shed light on functional or evolutionary relati...hrough and produce vast amounts of data. Everyday ...
Other Biology News:More animals join the learning circle 2Doctors should stop prescribing antibiotics for the common cold, review advises 2Drawing with DNA: 'Bioart' illuminates genomics 2Drawing with DNA: 'Bioart' illuminates genomics 3
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-...ttheNASDAQOMXconferenceonTuesday,December1stat1:45...tenvialiveaudiobroadcastovertheInternetavailableat...Userscanclickthe"Webcast"icontoaccessthisfile. ,...ifeScienceandHighTechnologycompany.Itschemicalandb...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/-...ompanyfocusedondevelopingandcommercializingnovelpa...onno,PresidentandChiefExecutiveOfficer,isscheduled...erence,tobeheldDecember1-2,2009atTheNewYorkPalaceH...higlieri,ChiefFinancialOfficer,willbeavailabletore...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatientsw..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEter...),aglobalbiopharmaceuticalcompanyfocusedonendocrin...datafromaPhase2studywithitstargetedcytotoxicpeptid...advancedorrecurrentendometrialcancer.Inapersonaliz...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCal...dthatRandyScott,GenomicHealth,sExecutiveChairman,w...ferenceinNewYorkCityonTuesday,December1,2009at10:0...vedwebcastofthepresentation,visittheInvestorRelati...or.genomichealth.com .Pleaseconnecttothewebsiteatl...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...armaceuticals, the proprietary products division o...Companies, Inc. (NYSE: PRX ) today,announced that... Inc.,(Amex: IMM ) has chosen to discontinue the ...nvestigative therapy., On February 22, 2008, Immt...rts of adverse events related to abnormal kidney f...
...agene Inc., a,biotechnology company that develops ... announced today that one of the Nature Research,J...he FACTORIAL(TM). In,advance online publication on...colleagues describes a novel and remarkably consis...tivity of a large panel of transcription,factors.,...
...l/ - Oncothyreon Inc. (Nasdaq,- ONTY) (TSX - ONY) ...f,data demonstrating the effectiveness of PX-478 i...8th Annual Targeted Therapies of the Treatment of,...on for the Study of Lung,Cancer in Santa Monica, C...2008, by Jorg J. Jacoby, Ph.D., Instructor, Univer...
Other Biology Technology:Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 2Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 3Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 2Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 3Oncothyreon's PX-478 is effective in preclinical model of human lung cancer 2Oncothyreon's PX-478 is effective in preclinical model of human lung cancer 3
...0 contains 400 unique human proteins on a 1x3 inch...a cross section of all cellular proteins, are arra...itional control proteins and a specific chip layou...NIchip protein microarrays are high-density protei...
...0 contains 400 unique human proteins on a 1x3 inch...all extracellular proteins (EP) according to Gene ...ate for high-quality results. Additional control p...validity and reproducibility., UNIchip protein mic...
...s are E.Coli glycerol stocks contained in standard...cDNA clones with approximately 5,000 clones per pl... plate well, the corresponding subplate is screene...ve well(s). Cells from a positive well are then pl...
...ed Reticulocyte Lysate Systems(a,b,c,d) offer rese...nslations: a single-tube, coupled transcription/tr...implify the process and reduce the time required t...bbit reticulocyte lysate translations (1) commonly...
Biology Products: